Sigilon Therapeutics

YTD

ALL

Why Robinhood?

You can watch SGTX and buy or sell other stocks, ETFs, and their options commission-free!

About SGTX

Sigilon Therapeutics, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutic treatments for a wide range of chronic diseases. Its program includes Rare Blood Disorders, Lysosomal Storage Diseases, and Endocrine and Other Chronic Diseases.

CEO

Rogério Vivaldi Coelho, MD, MBA

CEORogério Vivaldi Coelho, MD, MBA

Employees

—

Employees—

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2015

Founded2015

Employees

—

Employees—

SGTX Key Statistics

Market cap

56.49M

Market cap56.49M

Price-Earnings ratio

-1.86

Price-Earnings ratio-1.86

Dividend yield

—

Dividend yield—

Average volume

22.59K

Average volume22.59K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$28.00

52 Week high$28.00

52 Week low

$3.77

52 Week low$3.77

People also own

Based on the portfolios of people who own SGTX. This list is generated using Robinhood data, and it’s not a recommendation.